Your browser doesn't support javascript.
loading
Experiência clínica com a utilização de plugs vasculares Amplatzer / Clinical experience with Amplatzer vascular plugs
Pereira, Fabrício Leite; Ribeiro, Marcelo Silva; Costa, Rodrigo Nieckel; Braga, Sergio Luiz Navarro; Fontes, Valmir Fernandes; Pedra, Carlos Augusto Cardoso.
  • Pereira, Fabrício Leite; Instituto Dante Pazzanese de Cardiologia. Seção Médica de Intervenções em Cardiopatias congênitas. São Paulo. BR
  • Ribeiro, Marcelo Silva; Instituto Dante Pazzanese de Cardiologia. Seção Médica de Intervenções em Cardiopatias congênitas. São Paulo. BR
  • Costa, Rodrigo Nieckel; Instituto Dante Pazzanese de Cardiologia. Seção Médica de Intervenções em Cardiopatias congênitas. São Paulo. BR
  • Braga, Sergio Luiz Navarro; Instituto Dante Pazzanese de Cardiologia. Seção Médica de Intervenções em Cardiopatias congênitas. São Paulo. BR
  • Fontes, Valmir Fernandes; Instituto Dante Pazzanese de Cardiologia. Seção Médica de Intervenções em Cardiopatias congênitas. São Paulo. BR
  • Pedra, Carlos Augusto Cardoso; Instituto Dante Pazzanese de Cardiologia. Seção Médica de Intervenções em Cardiopatias congênitas. São Paulo. BR
Rev. bras. cardiol. invasiva ; 18(3): 327-336, set. 2010. ilus, tab
Article Dans Portugais | LILACS, SES-SP | ID: lil-566810
RESUMO

INTRODUÇÃO:

Os plugs vasculares Amplatzer I e II (PVAs I e II são dispositivos de nitinol autoexpansíveis e de baixo perfil desenvolvidos para oclusão de estruturas vasculares. Relatamos nossa experiência com esses dispositivos em dois centros brasileiros de referência.

Método:

Estudo retrospectivo dos pacientes que se submeteram a procedimentos de oclusão de estruturas vasculares diversas com PVAs desde 2005. Foram utilizadas próteses 30 por cento a 50 por cento maiores que o vaso-alvo, implantados sob anestesia geral por via nervosa femoral e jugular interna ou arterial femoral e braquial por cateteres terapêuticos ou bainhas longas 5 F a 8 F.

Resultados:

Foram identificados 14 pacientes (50 por cento do sexo masculino) com mediana de idade de 5 anos (11 meses a 70 anos) e mediana de peso de 15 Kg (8Kg a 67 Kg). Foram utilizados 17 plugs vasculares vasculares, sendo 2 PVAs II e15 PVAs I, com diâmetros de 4 mm a 16 mm. Em 3 pacientes existiam dois vasos para oclusão, sendo utilizados 2 PVAs em vasos diferentes. Em 3 pacientes com fístulas coronárias houve oclusão completa dos vasos após 24 horas. Em 2 pacientes com anastomoses...
ABSTRACT

BACKGROUND:

The Amplatzer® vascular plugs I and II (AVPs I and II) are low profile self-expandable devices made of nitinol, designed for vascular occlusions. We report our experience with these devices in two tertiary referral hospitals.

METHODS:

Retrospective study of patients undergoing vascular occlusion procedures with AVPs since 2005. The devices were 30%-50% larger than the target vessel, deployed under general anesthesia via femoral and internal jugular vein or femoral and brachial artery, and delivered through guiding catheters or 5 F to 8 F long sheaths.

RESULTS:

Fourteen patients (50% male) at a median age of 5 years (11 months to 70 years) and a median weight of 15 kg (8 kg to 67 kg) were identified. Seventeen AVPs were used 2 AVPs II and 15 AVPs I, with a diameter ranging from 4 mm to 16 mm. In 3 patients with more than one vessel to occlude, 2 AVPs were implanted in each vessel. In 3 patients with coronary fistula total occlusion of the vessels occurred after 24 hours. In 2 patients with modified Blalock-Taussig shunts, there was total occlusion of the anastomosis, with the use of additional coils in one. In 3 patients with venovenous fistulas after Glenn or Fontan operations, there was complete occlusion of the vessels and improved saturation, with the use of additional coils in one. Another patient with venovenous fistula had mild residual shunt in the lab and total occlusion observed at echocardiographic monitoring within 24 hours. Two patients with multiple pulmonary arteriovenous malformations underwent closure using the AVP, other Amplatzer devices and Gianturco's coils, with minimal residual shunts in all cases. In 2 patients with systemic-pulmonary collaterals in the postoperative period of pulmonary atresia and VSD repair, there was complete occlusion with the aid of additional coils, one immediately after the procedure and the other within 24 hours. In one patient with scimitar syndrome the systemic collateral vessel was totally occluded. There was no embolization or death.

CONCLUSIONS:

The AVPs were appropriate and flexible devices for occlusion of different vascular sites, with easy deployment and good occlusion rates. Additional coils were required in some cases. In these cases, AVPs worked well to anchor the coils.
Sujets)
Texte intégral: Disponible Indice: LILAS (Amériques) Sujet Principal: Implantation de prothèses vasculaires / Dispositif d'occlusion septale / Cardiopathies congénitales Type d'étude: Étude observationnelle / Facteurs de risque Limites du sujet: Femelle / Humains / Mâle langue: Portugais Texte intégral: Rev. bras. cardiol. invasiva Année: 2010 Type: Article Institution/Pays d'affiliation: Instituto Dante Pazzanese de Cardiologia/BR

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: LILAS (Amériques) Sujet Principal: Implantation de prothèses vasculaires / Dispositif d'occlusion septale / Cardiopathies congénitales Type d'étude: Étude observationnelle / Facteurs de risque Limites du sujet: Femelle / Humains / Mâle langue: Portugais Texte intégral: Rev. bras. cardiol. invasiva Année: 2010 Type: Article Institution/Pays d'affiliation: Instituto Dante Pazzanese de Cardiologia/BR